LXEO
#3104
Lexeo Therapeutics, Inc. - Common Stock
4.6 3 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.73%
Changement Mensuel
+11.57%
Evolution sur 6 mois
-33.19%
Changement Annuel
-2.94%
Clôture Précédente
4.7 6
Open
4.6 1
Low
4.5 6
High
4.6 4
Volume
104
Financials
- Market Capitalization 379.87 M
- Employee 59
- Founded 2017
- CEO N/A
- Website www.lexeotx.com
- Headquarter New York, United States
- FIGI BBG00YB1C8M5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3096 |  EYPT EyePoint, Inc. - Common Stock | 4.47 USD | -0.67% | -13.54% | -63.78% | -62.75% | 385.37 M USD | ||
| 3101 |  CTNM Contineum Therapeutics, Inc. - Common stock | 16.64 USD | +2.46% | -1.83% | +9.33% | +8.97% | 384.37 M USD | ||
| 3140 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.01 USD | -1.95% | -6.94% | -1.95% | +310.20% | 363.96 M USD | ||
| 3143 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.82 USD | +3.49% | -3.39% | +13.56% | -38.74% | 363.17 M USD |